RUA.NZ NZE
Rua Bioscience Limited
1W: -3.6%
1M: -22.9%
3M: -6.9%
YTD: -15.6%
1Y: -53.5%
3Y: -74.3%
5Y: -92.4%
NZ$0.03 ($0.02)
+0.00 (+3.70%)
Weekly Expected Move ±11.1%
NZ$0
NZ$0
NZ$0
NZ$0
NZ$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$7M
+5.9% ▲
5Y CAGR: -26.4%
Total Liabilities
$3M
+55.1% ▲
5Y CAGR: +6.1%
Shareholders Equity
$4M
-13.0% ▼
5Y CAGR: -32.8%
Cash & Investments
$534K
+121.1% ▲
5Y CAGR: -49.6%
Total Debt
$2M
+138.6% ▲
5Y CAGR: +13.0%
Net Debt
$1M
+147.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $2M | $3M | $895K | $241K | $534K |
| Short-Term Investments | $8M | $2M | $0 | $0 | $0 |
| Cash & ST Investments | $10M | $5M | $895K | $241K | $534K |
| Net Receivables | $1M | $863K | $277K | $357K | $525K |
| Inventory | $219K | $14K | $278K | $405K | $588K |
| Other Current Assets | $0 | $0 | $880K | $891K | $867K |
| Total Current Assets | $11M | $6M | $3M | $2M | $3M |
| Property, Plant & Equip. | $7M | $5M | $3M | $2M | $2M |
| Goodwill & Intangibles | $15M | $11M | $2M | $2M | $2M |
| Long-Term Investments | $75K | $75K | $75K | $75K | $75K |
| Other Non-Current Assets | $75K | $75K | $0 | $0 | $0 |
| Total Non-Current Assets | $22M | $15M | $5M | $4M | $4M |
| Total Assets | $34M | $21M | $8M | $7M | $7M |
| — Liabilities — | |||||
| Accounts Payable | $317K | $277K | $420K | $855K | $993K |
| Short-Term Debt | $129K | $0 | $0 | $657K | $2M |
| Deferred Revenue | $581K | $13K | $0 | $0 | $0 |
| Other Current Liabilities | $3M | $184K | $210K | $99K | $6K |
| Total Current Liabilities | $5M | $762K | $874K | $2M | $3M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $4M | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $5M | $68K | $99K | $38K | $25K |
| Total Liabilities | $9M | $830K | $973K | $2M | $3M |
| — Equity — | |||||
| Common Stock | $42M | $44M | $44M | $45M | $48M |
| Retained Earnings | -$18M | -$24M | -$38M | -$41M | -$44M |
| Accumulated OCI | $142K | $212K | $327K | $406K | $34K |
| Total Stockholders Equity | $24M | $20M | $7M | $5M | $4M |
| Total Liabilities & Equity | $34M | $21M | $8M | $7M | $7M |
| — Key Metrics — | |||||
| Total Debt | $824K | $115K | $148K | $736K | $2M |
| Net Debt | -$1M | -$2M | -$747K | $494K | $1M |
| Total Investments | $8M | $2M | $75K | $75K | $75K |